Yeah, but much like housing shortages, the classic cases of 'pharma bros' (Shkreli, et. al) is due in large part to the government. He, specifically, was able to jack prices because his company owned the patents (gov issued and controlled) and manufacturing license (gov issued) to rare but important drugs.